PARIET, ENTERIC-COATED TABLET 10MG
JANSSEN INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of PARIET, ENTERIC-COATED TABLET 10MG in Canada?
A shortage of PARIET, ENTERIC-COATED TABLET 10MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 7, 2026), but it has not started yet.
Why is PARIET, ENTERIC-COATED TABLET 10MG not available?
The reason the manufacturer reported: Demand increase for the drug.
When will PARIET, ENTERIC-COATED TABLET 10MG be available again?
The manufacturer's estimated resolution date is October 21, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Proton Pump Inhibitor (PPI) Shortage in Canada: Omeprazole, Pantoprazole, Rabeprazole
Why a shortage of one PPI brand rarely means the whole class is unavailable, when a pharmacist can swap manufacturers, and when it needs your prescriber.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
RIVA-RABEPRAZOLE EC
LABORATOIRE RIVA INC.
SANDOZ RABEPRAZOLE
SANDOZ CANADA INCORPORATED
DOM-RABEPRAZOLE EC
DOMINION PHARMACAL
Other Products
RABEPRAZOLE EC
MELIAPHARM INC
RABEPRAZOLE
SIVEM PHARMACEUTICALS ULC
PAT-RABEPRAZOLE
PATRIOT A DIVISION OF JANSSEN INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-10-21
~11 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02243796
Strength
10MG
Dosage Form
TABLET (ENTERIC-COATED)
Route
ORAL
Active Ingredient
RABEPRAZOLE SODIUM
Tier
Unrated
Last Updated
2026-10-07
Reason for Shortage
Demand increase for the drug.
Other Products from JANSSEN INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02538555
DIN 02538563
4MG · DIN 02493225
3MG · DIN 02493217
5MG · DIN 02493233
1.5MG · DIN 02397455
0.5MG · DIN 02397447
18MG · DIN 02247732
27MG · DIN 02250241
54MG · DIN 02247734
36MG · DIN 02247733
400MG · DIN 02455978